Chiu, Simon <br/><br/>
Liposomal-formulated curcumin [Lipocurc™] targeting HDAC (histone deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson's disease: implications for epigenetics-based nanotechnology-driven drug platform.  [electronic resource] 

 -  Journal of complementary & integrative medicine  Nov 2013 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1553-3840 
<br/><br/><label>Standard No.: </label>10.1515/jcim-2013-0020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Genetically Modified<br/>Apoptosis--drug effects<br/>Curcumin--administration & dosage<br/>Disease Models, Animal<br/>Dopaminergic Neurons--drug effects<br/>Exploratory Behavior--drug effects<br/>Gene Knockout Techniques<br/>Histone Deacetylase Inhibitors--administration & dosage<br/>Histone Deacetylases--drug effects<br/>Nootropic Agents--administration & dosage<br/>Parkinson Disease--drug therapy<br/>Psychomotor Disorders--drug therapy<br/>Random Allocation<br/>Rats